G1 Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
G1 Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2018 to Q2 2024.
  • G1 Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 322 %, a 28.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 322 -128 -28.4% Jun 30, 2024
Q1 2024 368 -97.5 -21% Mar 31, 2024
Q4 2023 409 -89.5 -18% Dec 31, 2023
Q3 2023 438 -136 -23.6% Sep 30, 2023
Q2 2023 450 -230 -33.9% Jun 30, 2023
Q1 2023 465 -361 -43.7% Mar 31, 2023
Q4 2022 498 -485 -49.3% Dec 31, 2022
Q3 2022 574 -423 -42.4% Sep 30, 2022
Q2 2022 680 -272 -28.5% Jun 30, 2022
Q1 2022 826 -135 -14.1% Mar 31, 2022
Q4 2021 983 +6.05 +0.62% Dec 31, 2021
Q3 2021 997 -77.6 -7.22% Sep 30, 2021
Q2 2021 952 -348 -26.8% Jun 30, 2021
Q1 2021 961 -520 -35.1% Mar 31, 2021
Q4 2020 977 -799 -45% Dec 31, 2020
Q3 2020 1.07K -1.07K -49.9% Sep 30, 2020
Q2 2020 1.3K -1.29K -49.9% Jun 30, 2020
Q1 2020 1.48K -1.04K -41.2% Mar 31, 2020
Q4 2019 1.78K -407 -18.6% Dec 31, 2019
Q3 2019 2.14K +443 +26.1% Sep 30, 2019
Q2 2019 2.59K +1.34K +107% Jun 30, 2019
Q1 2019 2.52K +1.3K +106% Mar 31, 2019
Q4 2018 2.18K Dec 31, 2018
Q3 2018 1.7K Sep 30, 2018
Q2 2018 1.25K Jun 30, 2018
Q1 2018 1.23K Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.